Mead Johnson Nutrition Company (Mead Johnson), founded in 1905 and headquartered in Chicago, Illinois, manufactures and markets science-based pediatric nutrition products, with a focus on infant formulas and children's nutritional supplements; its flagship brands include Enfamil standard and specialized formulas, Nutramigen hypoallergenic lactose-free formulas for cow's milk allergy and colic relief, EnfaProSobee soy-based options, Enfalyte oral rehydration solutions, metabolic formulas for specific medical needs, and Enfagrow toddler nutrition products containing DHA and ARA for brain and eye development. The company operates globally across North America, Latin America, Europe, and Asia, serving mothers, healthcare professionals, and retailers in over 50 countries through a network of manufacturing facilities including sites in Evansville, Indiana; Zeeland, Michigan; and Nijmegen, Netherlands. As an independent subsidiary of Reckitt, Mead Johnson maintains key research and development centers, with its largest U.S. facility in Evansville. In July 2024, Reckitt designated Mead Johnson as a non-core asset and initiated a strategic review to explore all options including a potential sale to maximize shareholder value, with the process advancing through 2025 and low-to-mid single-digit like-for-like net revenue growth projected for the year; recent operational developments include an $836 million investment proposal for facility upgrades and rezoning approvals in Zeeland, Michigan, alongside a 120th anniversary celebration in August 2025 highlighting its innovation legacy; earlier, in 2024, the company navigated supply chain disruptions from a tornado at a key distribution center while achieving 30% growth in emerging markets like Asia and Latin America under Reckitt's "Fuel for Growth" strategy.